P3 Health Partners Inc. (PIII)
Price:
2.12 USD
( - -0.10 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Aveanna Healthcare Holdings Inc.
VALUE SCORE:
5
2nd position
Option Care Health, Inc.
VALUE SCORE:
9
The best
Addus HomeCare Corporation
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
NEWS

P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey
defenseworld.net
2025-12-31 01:26:54P3 Health Partners (NASDAQ: PIII - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership. Analyst Recommendations This is a

Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)
defenseworld.net
2025-12-21 02:14:49P3 Health Partners (NASDAQ: PIII - Get Free Report) and Mobile-health Network Solutions (NASDAQ: MNDR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Volatility and Risk P3 Health

KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey
defenseworld.net
2025-12-18 01:43:02P3 Health Partners (NASDAQ: PIII - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility P3 Health

P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast
defenseworld.net
2025-12-03 01:58:50P3 Health Partners (NASDAQ: PIII - Get Free Report) and CVR Medical (OTCMKTS:CRRVF - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Volatility and Risk P3 Health Partners has

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
businesswire.com
2025-12-02 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of pri.

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference
newsfilecorp.com
2025-11-24 16:05:00Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m.

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-14 09:51:32P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

P3 Health Partners Announces Third Quarter 2025 Results
businesswire.com
2025-11-13 17:30:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. “Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model,” said Aric Coffman, CEO of P3. “Medical cost trends, normalized for prior-year adjustments, remain sta.

P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
businesswire.com
2025-10-21 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webc.

P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
businesswire.com
2025-09-17 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3.

Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
prnewswire.com
2025-08-25 09:30:00GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025.

P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-14 22:20:31P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
zacks.com
2025-08-14 18:15:19P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.

P3 Health Partners Announces Second Quarter 2025 Results
businesswire.com
2025-08-14 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp.

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call
businesswire.com
2025-07-31 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Sec.
No data to display

P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey
defenseworld.net
2025-12-31 01:26:54P3 Health Partners (NASDAQ: PIII - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership. Analyst Recommendations This is a

Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)
defenseworld.net
2025-12-21 02:14:49P3 Health Partners (NASDAQ: PIII - Get Free Report) and Mobile-health Network Solutions (NASDAQ: MNDR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Volatility and Risk P3 Health

KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey
defenseworld.net
2025-12-18 01:43:02P3 Health Partners (NASDAQ: PIII - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility P3 Health

P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast
defenseworld.net
2025-12-03 01:58:50P3 Health Partners (NASDAQ: PIII - Get Free Report) and CVR Medical (OTCMKTS:CRRVF - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Volatility and Risk P3 Health Partners has

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
businesswire.com
2025-12-02 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of pri.

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference
newsfilecorp.com
2025-11-24 16:05:00Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m.

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-14 09:51:32P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

P3 Health Partners Announces Third Quarter 2025 Results
businesswire.com
2025-11-13 17:30:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. “Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model,” said Aric Coffman, CEO of P3. “Medical cost trends, normalized for prior-year adjustments, remain sta.

P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
businesswire.com
2025-10-21 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webc.

P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
businesswire.com
2025-09-17 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3.

Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
prnewswire.com
2025-08-25 09:30:00GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025.

P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-14 22:20:31P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
zacks.com
2025-08-14 18:15:19P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.

P3 Health Partners Announces Second Quarter 2025 Results
businesswire.com
2025-08-14 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp.

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call
businesswire.com
2025-07-31 16:05:00HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Sec.










